News & Presentations
Previous Article   |   Next Article
Innovation Platform, RNS Announcements | 24 Apr 2013

Nutrition Science Partners announces initiation and treatment of the first Ulcerative Colitis patient in the global NATRUL Phase III trial for the novel botanical oral drug HMPL-004